- Home
- EQ vs PED Comparison
EQ vs PED Comparison
Compare EQ & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQ | PED |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.5M | 152.8M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | EQ | PED |
|---|---|---|
| Price | $2.21 | $14.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.00 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 423.3K | 16.9K |
| Earning Date | 05-25-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $41,095,000.00 | ★ $45,751,000.00 |
| Revenue This Year | N/A | $171.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.67 |
| 52 Week Low | $0.76 | $0.43 |
| 52 Week High | $3.54 | $18.89 |
Technical Indicators
Market Signals| Indicator | EQ | PED |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 62.91 |
| Support Level | $2.15 | $12.89 |
| Resistance Level | $2.58 | $16.70 |
| Average True Range (ATR) | 0.16 | 0.64 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 10.00 | 85.29 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).